KR880000448A - 세팔로스포린 유도체의 제조방법 - Google Patents

세팔로스포린 유도체의 제조방법 Download PDF

Info

Publication number
KR880000448A
KR880000448A KR1019860005101A KR860005101A KR880000448A KR 880000448 A KR880000448 A KR 880000448A KR 1019860005101 A KR1019860005101 A KR 1019860005101A KR 860005101 A KR860005101 A KR 860005101A KR 880000448 A KR880000448 A KR 880000448A
Authority
KR
South Korea
Prior art keywords
group
alkyl
compound
following formula
carbon atoms
Prior art date
Application number
KR1019860005101A
Other languages
English (en)
Other versions
KR890002107B1 (ko
Inventor
이철해
김경숙
김경수
Original Assignee
재단법인 한국화학연구소
채영복
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 한국화학연구소, 채영복 filed Critical 재단법인 한국화학연구소
Priority to KR1019860005101A priority Critical patent/KR890002107B1/ko
Priority to JP62155237A priority patent/JPS6322570A/ja
Priority to DE19873744772 priority patent/DE3744772A1/de
Priority to IT21014/87A priority patent/IT1205178B/it
Priority to DE19873720681 priority patent/DE3720681A1/de
Priority to GB08714764A priority patent/GB2195334A/en
Publication of KR880000448A publication Critical patent/KR880000448A/ko
Application granted granted Critical
Publication of KR890002107B1 publication Critical patent/KR890002107B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용 없음

Description

세팔로스포린 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 화합물과 반응시켜 얻어진 반응성 유도체를 하기 일반식 (Ⅳ)의 화합물과 반응시킴을 특징으로 하는 하기 일반식(Ⅰ)의 화합물의 Syn이성체를 제조하는 방법.
    식중, R은 푸릴기, 티아졸릴기, 티아디졸릴기를 나타내며 R1은 6 개 이하의 탄소원자를 갖는 알킬, 알케닐, 알키닐 또는 시클로알킬기들을 나타낸다. Z은 수소 또는 할로겐 원자이거나 5 개 이하의 탄소원자를 갖는 알킬, 시클로알킬, 알콕시 또는 알킬티오기, 또는 아세톡시메틸 또는 카르바모일옥시메틸기, 또는 R2가 S 및 N에서 선택된 임의로 치환된 1-4개의 헤테로 원자를 함유하는 5-6개의 고리를 가진 헤테로사이클을 나타내는 경우의-CH2-S-R2기, 혹은 -CH-R2기, 또는나기를 나타내며, R3는 수소 또는 1-5개의 탄소원자를 가진 알킬, 에스테르, 유기산, 또는 아미드기를 나타낸다. M은 수소원자, 알칼리나, 알칼리토금속, 또는 에스테르기를 나타내며 COOM기는 CO2를 나타내기도 하며 Z이를 나타내는 경우 COOM는 C00-를 나타낸다.
    상기 일반식(Ⅲ)에서 R4는 알킬 또는 아릴기를 나타낸다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860005101A 1986-06-25 1986-06-25 세팔로스포린 유도체의 제조방법 KR890002107B1 (ko)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1019860005101A KR890002107B1 (ko) 1986-06-25 1986-06-25 세팔로스포린 유도체의 제조방법
JP62155237A JPS6322570A (ja) 1986-06-25 1987-06-22 １−メタンスルホニルオキシ−６−トリフルオロメチル−１ｈ−ベンゾトリアゾ−ル及びセファロスポリン誘導体の製造方法
DE19873744772 DE3744772A1 (ko) 1986-06-25 1987-06-23
IT21014/87A IT1205178B (it) 1986-06-25 1987-06-23 1-metansolfonilossi-6-trifluorometi l-1h-benzotriazolo e il suo impiego per preparare derivati della cefalosporina
DE19873720681 DE3720681A1 (de) 1986-06-25 1987-06-23 1-methansulfonyloxy- und p-toluolsulfonyloxy-6-trifluormethyl-1h-benzotriazol, 2-heterocyclyl-2-syn-oxyiminoessigsaeure-5-trifluormethyl-1h-benzotriazol-1-yl-ester und deren verwendung zur herstellung von cephalosporinderivaten
GB08714764A GB2195334A (en) 1986-06-25 1987-06-24 1-Methanesulfonyloxy-6-trifluoromethyl-1H-benzotriazole and its use in preparing cephalosporin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019860005101A KR890002107B1 (ko) 1986-06-25 1986-06-25 세팔로스포린 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR880000448A true KR880000448A (ko) 1988-03-25
KR890002107B1 KR890002107B1 (ko) 1989-06-19

Family

ID=19250716

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860005101A KR890002107B1 (ko) 1986-06-25 1986-06-25 세팔로스포린 유도체의 제조방법

Country Status (5)

Country Link
JP (1) JPS6322570A (ko)
KR (1) KR890002107B1 (ko)
DE (2) DE3720681A1 (ko)
GB (1) GB2195334A (ko)
IT (1) IT1205178B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR890100706A (el) * 1989-10-31 1992-03-20 Han Mi Pharma Ind Co Ltd Μέ?οδος παρασκευής παραγώγων κεφέμης.
AT398764B (de) * 1992-01-28 1995-01-25 Lek Tovarna Farmacevtskih Verfahren zur herstellung von ceftriaxondinatrium-salzhemiheptahydrat
AT399877B (de) * 1992-02-20 1995-08-25 Biochemie Gmbh Neues verfahren zur herstellung von ceftriaxon
WO1996012712A1 (en) * 1994-10-24 1996-05-02 Miwon Co., Ltd. Reactive phosphate derivatives of thiazolylacetic acid and process for preparing cephalosporin antibiotics using the same
KR100197788B1 (ko) * 1995-06-30 1999-06-15 김충환 세펨 유도체의 제조방법

Also Published As

Publication number Publication date
KR890002107B1 (ko) 1989-06-19
IT1205178B (it) 1989-03-15
IT8721014A0 (it) 1987-06-23
DE3744772A1 (ko) 1989-02-02
GB8714764D0 (en) 1987-07-29
JPS6322570A (ja) 1988-01-30
DE3720681A1 (de) 1988-01-28
GB2195334A (en) 1988-04-07

Similar Documents

Publication Publication Date Title
KR850004757A (ko) 치환 트란스-1, 2-디아미노싸이클로헥실 아미드 화합물의 제법
KR840000483A (ko) 유기화합물의 개량
IE780078L (en) 11-beta substituted steroids
KR850001905A (ko) 벤조시클로 알칸 유도체의 제조방법
KR880000448A (ko) 세팔로스포린 유도체의 제조방법
ATE83772T1 (de) Antihypercholesterolemische 4,5-diaryl-2substituierte thioimidazole.
AU562253B2 (en) Thiazolothienoazepine or pyridiue derivatives
KR850000455A (ko) 세팔로스포린 에스테르 유도체의 제조방법
AU526539B2 (en) 2-(3,4-disubstituted-phenylimino)-imidazolidines
GB2017087A (en) Process for the preparation of xanthone derivatives
KR880001673A (ko) 세팔로스포린 유도체의 제조방법
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
RU97112159A (ru) Диклавулановая соль диаминового эфира и способ ее приготовления
KR930007880A (ko) 비스(페닐)에탄 유도체
KR890011830A (ko) 2-옥시이미노 -3- 옥소부티르산의 제조방법
KR890006562A (ko) 할로겐화 프로테아제 억제제 제조용 중간체 및 그 방법
ES447615A1 (es) Un procedimiento para obtener compuesto de cefalosporina.
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR920002564A (ko) N-알킬 티아졸리딘 유도체
KR890002178A (ko) 신규한 세펨 화합물
KR870010062A (ko) 세파로스포린 유도체의 제조방법
KR890002176A (ko) 신규한 세펨 화합물
KR920002613A (ko) 이환성 함유 황화합물
KR880003957A (ko) 세팔로스포린 유도체의 제조방법
ES8106149A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-sulfinil-5-sulfonil-1,3,4-tiadiazol

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020208

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee